Consistent with this finding, comparing p16 expression within tumors of each histological type also revealed significant differences; in serous, mucinous, and endometriosis-associated neoplasms, stromal p16 expression in malignant and borderline lesions was significantly higher than that of borderline and benign lesions, respectively. This evidence concerns the gene CDKN2A and neoplasm.